国际标准期刊号: 2167-065X

临床药理学与生物药剂学

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • Genamics 期刊搜索
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Innovative Approach to Diagnosis, Risk Factor, and Management of Gestational Diabetes Mellitus (Gdm)?Mother and Offspring

Krishna Babu Ojha, Anurag, Soumyadip Mukherjee, Ravi Rajput, Rupali Vinod Yadav

Background: One of the main barriers for obtaining improved maternal and child health is Gestational Diabetes Mellitus. it affects around 5% of pregnancies that increases the risk of caesarean and surgical vaginal birth, macrosomia, shoulder dystocia, neonatal hypoglycaemia, and hyperbilirubinemia for both the mother and the unborn child. In this review article we focused on the various parameters that affects Gestational diabetes mellitus like, pathophysiology, epidemiology, risk factors and treatment.

Body: An extensive literature review was done from the standard databases such as Scopus, Elsevier, and PubMed using standard keywords “Gestational Diabetes”, “Diabetes”, “Pregnancy disorder”. Here, we explore the effects of Gestational Diabetes Mellitus on long- term maternal and newborn outcomes as well as health concerns that will probably last into the next generation. We discuss current clinical survey data and model of Gestational Diabetes Mellitus to better understand the underlying pathophysiology of the disease and the timely need to expand our scientific toolbox in order to identify strategies to prevent and treat Gestational Diabetes Mellitus.

Conclusion: While discussing about the gestational diabetes mellitus with the advance clinical care, in addition to the challenges currently faced in the Epidemiology, and techniques of diagnosis, Pathophysiology, risk factor, management of Gestational Diabetes Mellitus.